Biotalys Raises €12.05M in Private Placement to Strengthen Capital Base
Event summary
- Biotalys NV closed a private placement of 7,875,811 new shares at €1.53 per share, raising €12.05M.
- The new shares represent approximately 20.96% of the company’s shares outstanding prior to the transaction.
- Investors include existing shareholders such as Ackermans & van Haaren NV and Agri Investment Fund BV.
- New shares will be listed on Euronext Brussels on May 22, 2026.
- The capital increase was approved by a committee of independent directors and the board of directors.
The big picture
Biotalys' €12.05M private placement reflects a strategic move to bolster its capital base amid a competitive AgTech landscape. The involvement of existing investors underscores confidence in the company's AGROBODY™ technology platform, which aims to bridge the efficacy of chemical solutions with the environmental benefits of biological alternatives. This funding round positions Biotalys to accelerate its pipeline of crop protection solutions, addressing key pests and diseases across the agricultural value chain.
What we're watching
- Capital Deployment
- How Biotalys will allocate the €12.05M to advance its AGROBODY™ technology platform and pipeline.
- Shareholder Dynamics
- Whether the dilution from the private placement will impact existing shareholders' influence.
- Market Positioning
- The pace at which Biotalys can scale its precision biocontrol solutions in the competitive AgTech market.
Related topics